Back to results
US 10,946,071 B2Granted
Combination of ibudilast and interferon-beta and methods of using same
AssigneeMediciNova, Inc.
InventorKazuko Matsuda
Life of this patent
Estimating the term…
Abstract
This disclosure is directed to methods of alleviating the negative effects of, treating, or slowing the progression of progressive multiple sclerosis in human patients using ibudilast and interferon-beta.
Claims17
A method of (i) alleviating the negative effects of a progressive multiple sclerosis in a human patient in need thereof, (ii) treating a progressive multiple sclerosis in a human patient in need thereof, or (iii) slowing the progression of a progressive multiple sclerosis in a human patient in need thereof, the method comprising administering to the human patient:
- (a) a therapeutically effective amount of ibudilast or a pharmaceutically acceptable salt thereof, and
- (b) a therapeutically effective amount of interferon-beta;
- wherein the ibudilast, or pharmaceutically acceptable salt thereof, and the interferon-beta are administered in separate dosage forms.
Dependencies are inferred from the claim text.